DE1289668B - Stabilizing agent for enzymatic test reagents - Google Patents

Stabilizing agent for enzymatic test reagents

Info

Publication number
DE1289668B
DE1289668B DE1964B0074973 DEB0074973A DE1289668B DE 1289668 B DE1289668 B DE 1289668B DE 1964B0074973 DE1964B0074973 DE 1964B0074973 DE B0074973 A DEB0074973 A DE B0074973A DE 1289668 B DE1289668 B DE 1289668B
Authority
DE
Germany
Prior art keywords
stabilizing agent
test reagents
enzymatic test
enzymatic
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1964B0074973
Other languages
German (de)
Inventor
Bergmeyer
Dr Rer Nat Hans Ulrich
Bernt Erich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
CF Boehringer und Soehne GmbH
Original Assignee
Boehringer Mannheim GmbH
CF Boehringer und Soehne GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH, CF Boehringer und Soehne GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE1964B0074973 priority Critical patent/DE1289668B/en
Publication of DE1289668B publication Critical patent/DE1289668B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/008Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions for determining co-enzymes or co-factors, e.g. NAD, ATP
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose

Description

1 21 2

Um enzymatische Untersuchungen (ζ. B. die Mes- Die nach der Lehre der vorliegenden ErfindungTo enzymatic investigations (ζ. B. the Mes- Die according to the teaching of the present invention

sung von Enzym-Aktivitäten für diagnostische erhältlichen Reagenzienkompositionen sind, so her-solution of enzyme activities for diagnostically available reagent compositions,

Zwecke) routinemäßig und rasch durchführen zu gestellt, in Wasser sehr schnell und leicht lösliche,Purposes) to be carried out routinely and quickly, very quickly and easily soluble in water,

können, ist es für den Praktiker von großer Bedeu- poröse Pulver, die jahrelang haltbar sind. Sie stellen tung, die für den Ablauf der betreffenden enzyma- 5 einen erheblichen Fortschritt auf dem Gebiete derit is of great importance for the practitioner - porous powders that can be kept for years. they provide processing, which for the expiry of the relevant enzyme 5 represents a considerable advance in the field of

tischen Reaktion erforderlichen Stoffe (Hilfsenzyme, Reagenzien-Zusammenstellungen für enzymatischesubstances required for the reaction (auxiliary enzymes, reagent combinations for enzymatic

Coenzyme, Substrate, Puffersubstanzen usw.) ge- Untersuchungen dar. Der Praktiker hat nunmehrCoenzymes, substrates, buffer substances, etc.) are investigations. The practitioner now has

brauchsfertig — im richtigen Verhältnis dosiert — weiter nichts zu tun, als den Inhalt des betreffendenready for use - dosed in the right proportion - nothing more to do than the content of the relevant item

zur Verfugung zu haben. Behälters in einer bestimmten Menge Wasser zuavailable. Container in a certain amount of water

Im Interesse der Arbeitsrationalisierung soll eine io lösen, die zu untersuchende Substanz hinzuzugebenIn the interests of rationalization of work, an io should solve to add the substance to be examined

Reagenzienkomposition für enzymatische Unter- und gemäß Vorschrift zu messen (z. B. Messung derTo measure the reagent composition for enzymatic under- and according to instructions (e.g. measurement of the

suchungen schon möglichst viele der zur Durchfüh- Extinktion in einem Photometer),searches already as many of the extinctions to be carried out in a photometer),

rung der betreffenden Reaktion benötigten Stoffe ver- Im folgenden sind einige ReagenzienkompositionenThe following are some reagent compositions

einen, um zeitraubende Pipettierungen u. dgl. sowie angegeben, bei denen erfindungsgemäß Glutathionone, around time-consuming pipetting and the like, and indicated in which, according to the invention, glutathione

Fehlerquellen auf ein Minimum herabzusetzen. 15 als Stabilisierungsmittel Verwendung findet.Reduce sources of error to a minimum. 15 is used as a stabilizer.

So sind Diagnostiziermittel bekannt, die sämtlicheDiagnostic means are known that all

für den enzymatischen Nachweis einer Verbindung BeispieleExamples for the enzymatic detection of a compound

erforderlichen Substanzen enthalten. In der deutschen j Bestimmunecontain required substances. In the German j determination

Auslegeschrift 1 075 869 ist ein Testreagenz für der Glutamat-Pyruvat-Transaminase (GPT)Auslegeschrift 1,075,869 is a test reagent for the glutamate-pyruvate transaminase (GPT)

Glucose beschrieben, das die Komponenten auf ao ττργ» ο Glucose described, which the components on ao ττργ » ο

einem saugfähigen Träger aufweist. Die für die Test- tf6 § ^a?ViJ;4 ' ί comprises an absorbent carrier. The for the test- tf 6 § ^ a ? ViJ; 4 ' ί

reaktion erforderlichen Reagenzien können auch in ϊ'η< ai · ^ Reagents required for the reaction can also be expressed in ϊ'η <ai · ^

Pulverform vorliegen, wobei die Herstellung der f'«8101;,,"1,' . Powder form, the production of the f '«8101;,," 1 ,'.

trockenen Reagenzienkomposition, wie in der bei- U,35 g a-Ketoglutarat,dry reagent composition, as in the at- U, 35 g a-ketoglutarate,

gischen Patentschrift 627 961 beschrieben, durch 25 005ΌΡΝΗ "'gischen patent specification 627 961 described by 25 005ΌΡΝΗ "'

Gefriertrocknung der Lösungen zu sehr aktiven und .'„„Α ΎJ ^ ~ , Λ Freeze-drying of the solutions to very active and. '„„ Α Ύ J ^ ~, Λ

schnell wieder in Lösung gehenden Präparaten führt. 0,0015 gLactat-Dehydrogenase,dissolving preparations quickly. 0.0015 g lactate dehydrogenase,

Die in vielen Testkombinationen notwendigen U,3U g LrlutatnionThe U, 3U g Lrlutation required in many test combinations

beiden Coenzyme Di- und Triphosphopyridinnucleo- werden in 90 ml bidest. Wasser gelöst und der pH-both coenzymes di- and triphosphopyridine nucleo- are redistilled in 90 ml. Dissolved in water and the pH

tid müssen, um voll aktiv zu sein, in reduzierter 30 Wert mit verdünnter Natronlauge auf 7,6 eingestellt.In order to be fully active, tid must be set to a reduced 30 value with dilute sodium hydroxide solution to 7.6.

Form vorliegen (DPNH und TPNH). Leider sind sie Dann wird die Lösung mit bidest. Wasser auf 100 mlForm (DPNH and TPNH). Unfortunately they are then the solution with bidistilled. Water to 100 ml

in dieser Form nicht sehr stabil. aufgefüllt, anschließend eingefroren und lyophisiert.not very stable in this form. filled up, then frozen and lyophized.

Aufgabe der vorliegenden Erfindung ist es, einThe object of the present invention is to provide a

Stabilisierungsmittel zu finden, das die Stabilisierung 2. BestimmungFinding stabilizers that stabilize the 2nd determination

dieser Coenzyme bewirkt, jedoch sonst praktisch 35 der Glutamat,Oxalacetat-Transaminase (GOT)this coenzyme causes, but otherwise practically 35, the glutamate, oxaloacetate transaminase (GOT)

keinen Einfluß, zumindest nicht negativer Art, auf 2 43 s Na HPO · 2 H Ono influence, at least not of a negative kind, on 2 43 s Na HPO · 2 HO

die Testreaktionen ausübt. 0^21 g NaH^ · 2 HAcarries out the test reactions. 0 ^ 21 g NaH ^ 2 HA

Es wurde nun überraschenderweise festgestellt, 1,80 g Natriumaspartat;It has now surprisingly been found that 1.80 g of sodium aspartate;

daß als Stabilisierungsmittel für enzymatische Test- 0 35 ε α-Ketoglutaratthat as a stabilizer for enzymatic test 0 35 ε α-ketoglutarate

reagenzien, welche das Di- oder Triphosphopyri- 40 030 g Serumalbumin',reagents containing the di- or triphosphopyri- 40 030 g serum albumin ',

dinnucleotid in reduzierter Form enthalten, Glut- 0 05 2 DPNHContains dinnucleotide in reduced form, Glut- 0 05 2 DPNH

athion mit Erfolg verwendet werden kann, wobei das 0'0015 Lact'at-Dehydrogenase,athion can be used with success, the 0 ' 0015 Lact'at dehydrogenase,

Glutathion in reduzierter Form also mit freier 0,0015 g Malat-Dehydrogenase,Glutathione in reduced form, i.e. with free 0.0015 g malate dehydrogenase,

SM-Gruppe vorliegen muß. Durch die erfindungs- 0 3Oe GlutathionSM group must be present. By the invention 0 3Oe glutathione

gemäße Verwendung des Glutathione gelingt es nun, 45 'proper use of the glutathione now succeeds 45 '

diese Coenzyme in Mischungen mit den anderen er- Aufbereitung wie im Beispiel 1 angegeben,
forderlichen Reagenzien auch bei längerer Lagerung
these coenzymes in mixtures with the other preparation as indicated in example 1,
necessary reagents even after long periods of storage

aktiv zu halten. 3. Bestimmung der Lactat-Dehydrogenase (LDH)keep active. 3. Determination of lactate dehydrogenase (LDH)

Die Herstellung der Reagenzienkompositionen er- 2,43 g Na2HPO4 · 2 H2O,The preparation of the reagent compositions requires 2.43 g Na 2 HPO 4 · 2 H 2 O,

folgt durch Mischen aller für die Durchführung der 50 o,21 g NaH2PO4 · 2 H0O,follows by mixing all of the 50 o, 21 g NaH 2 PO 4 · 2 H 0 O,

bezweckten enzymatischen Reaktionen erforderlichen 0,004 g Natriumpyruvat,intended enzymatic reactions required 0.004 g sodium pyruvate,

Stoffe wie Hilfsenzyme, Coenzyme, Substrate, Puffer- o'3O g Serumalbumin,Substances such as auxiliary enzymes, coenzymes, substrates, buffers o'3O g serum albumin,

substanzen, Hilfsstoffe und dem erfindungsgemäßen o,O5 g DPNH,substances, auxiliaries and the o, O5 g DPNH according to the invention,

Stabilisator sowie gegebenenfalls Füllstoffe in dem 0,30 g Glutathion,Stabilizer and optionally fillers in the 0.30 g glutathione,

für den Ablauf der Testreaktionen optimalen Ver- 55 ' .._,.., Λ , the optimal 55 '.._, .., Λ ,

hältnis mit Wasser zu einer Lösung, deren Volumen Aufbereitung wie im Beispiel 1 angegeben.ratio with water to a solution, the volume of which is prepared as in Example 1.

und pH-Wert in üblicher Weise eingestellt werden 4_ Bestim von ^01386 (ALD) and pH value can be adjusted in the usual way 4 _ Determination of ^ 01386 (ALD)

kann. Diese Testlosungen werden dann gemäß der troncan. These test solutions are then processed according to the tron

jeweils gewünschten Einheitsmenge auf geeignete r^? S ^.a|?pjr* ' ;r iprj'each desired unit amount to suitable r ^? S ^. a |? pjr * '; r iprj'

Behälter aufgeteilt und durch Gefriertrocknung 60 £2* S NaH2PO4 ·.2H2C>>Divided container and freeze-drying 60 £ 2 * S NaH 2 PO 4 · .2H 2 C >>

(Lyophilisierung) des Inhalts dieser Behälter und 0,14 g Fructose-l,6-diphsophat,(Lyophilization) of the contents of these containers and 0.14 g of fructose-1,6-diphsophate,

sofortigen Verschluß derselben in haltbare Test- ">™5 g Jodacetat,immediate closure of the same in durable test "> ™ 5 g iodine acetate,

Präparate übergeführt. °>30 g Serumalbumin,Prepared transferred. °> 30 g serum albumin,

Als Füllstoffe können solche mchtionogenen orga- ^ ™Ä- ™ , , τ^ , jSuch mchtionogenic orga- ^ ™ Ä- ™,, τ ^, j

nischen Verbindungen verwendet werden, weiche 65 0,0015 g Glycerophosphat-Dehydrogenase,niche compounds are used, soft 6 5 0.0015 g glycerophosphate dehydrogenase,

— wie Gelatine, Polyvinylpyrrolidon, Albumin 0;0015gTriosephosphat-Isomerase,- such as gelatin, polyvinylpyrrolidone, albumin 0 ; 0015gtriosephosphate isomerase,

usw. — in an sich bekannter Weise den Lyophilisie- υ' § Wutatnion.etc. - in a manner known per se the lyophilization υ '3υ § Wutatnion.

rungsvorgang erleichtern. Aufbereitung wie im Beispiel 1 angegeben.facilitate the process. Preparation as indicated in Example 1.

Claims (1)

Patentanspruch:Claim: Verwendung von Glutathion als Stabilisierungsmittel für enzymatische Testreagenzien, welche Di- oder Triphosphopyridmnucleotid in reduzierter Form enthalten.Use of glutathione as a stabilizer for enzymatic test reagents which Contain di- or triphosphopyride nucleotide in reduced form.
DE1964B0074973 1964-01-14 1964-01-14 Stabilizing agent for enzymatic test reagents Pending DE1289668B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE1964B0074973 DE1289668B (en) 1964-01-14 1964-01-14 Stabilizing agent for enzymatic test reagents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1964B0074973 DE1289668B (en) 1964-01-14 1964-01-14 Stabilizing agent for enzymatic test reagents
DEB0090269 1966-12-12

Publications (1)

Publication Number Publication Date
DE1289668B true DE1289668B (en) 1969-02-20

Family

ID=25966935

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1964B0074973 Pending DE1289668B (en) 1964-01-14 1964-01-14 Stabilizing agent for enzymatic test reagents

Country Status (1)

Country Link
DE (1) DE1289668B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043530A1 (en) * 1980-07-03 1982-01-13 C.H. Boehringer Sohn Process and reagent for determining uric acid
EP0052780A1 (en) * 1980-11-26 1982-06-02 Roche Diagnostics GmbH Stabilized enzyme preparation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE627961A (en) * 1962-02-05
DE1075869B (en) * 1955-06-09 1960-02-18

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1075869B (en) * 1955-06-09 1960-02-18
BE627961A (en) * 1962-02-05

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043530A1 (en) * 1980-07-03 1982-01-13 C.H. Boehringer Sohn Process and reagent for determining uric acid
EP0052780A1 (en) * 1980-11-26 1982-06-02 Roche Diagnostics GmbH Stabilized enzyme preparation

Similar Documents

Publication Publication Date Title
DE1930059A1 (en) Stabilized enzymatic test reagents
Veloso et al. The concentrations of free and bound magnesium in rat tissues: Relative constancy of free Mg2+ concentrations
Crosby et al. A modification of the benzidine method for measurement of hemoglobin in plasma and urine
EP0009076B1 (en) Method for the quantitative enzymatic determination of adp and reagent for this method
DE1598321A1 (en) Laboratory reagent for the determination of creatine kinase
US3721607A (en) Reagent composition and process for the determination of glucose
US5585466A (en) Crystals of serum albumin for use in genetic engineering and rational drug design
EP0015437A1 (en) Method and reagent for the determination of creatine kinase
US3791931A (en) Reagent and method for determination of lactate dehydrogenase
US4057615A (en) Method of tagging excipients with 99M technetium
GB1584282A (en) Stabilized iodine tincture
DE1940816B2 (en) METHOD AND DIAGNOSTIC AGENT FOR THE ENZYMATIC DETERMINATION OF GLUCOSE
DE2617895C3 (en) Dispersion for the manufacture of an injectable radiopharmaceutical scanning agent
DE1289668B (en) Stabilizing agent for enzymatic test reagents
Loewus et al. A Potentiometric Study of the Change in Iodine Binding Capacity of Amylose while Retrograding in Dilute Solution1
DE2301999A1 (en) ENZYMATIC TEST
DE2932748A1 (en) METHOD FOR DETERMINING TRANSAMINASE IN A BIOLOGICAL LIQUID, AND REAGENT THEREFOR
DE2740957A1 (en) STABILIZED LIQUID ENZYME AND COENZYME MASSES AND THE PROCESS FOR THEIR PRODUCTION
DE3007402C2 (en) Process for reducing pertechnetate
US3992197A (en) Silver crystals and production thereof
DE2302721C2 (en) Method for the determination of creatine kinase
Ciaranfi et al. Time-course of injected acetate in normal and depancreatized dogs
DE2711754C2 (en) Method for stabilizing an enzyme which is unstable in an aqueous medium
US3746625A (en) Stabilized coenzyme test compositions
Lang et al. Effects of aldosterone and vasopressin on adenyl cyclase activity of rat kidney

Legal Events

Date Code Title Description
E77 Valid patent as to the heymanns-index 1977